Twitter Facebook LinkedIn

Heat Biologics, Inc. Heat Biologics, Inc.

  • Home
  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Pelican Therapeutics
    • Heat Biologics Mask
  • Technology
    • gp96 Platform
    • Pelican’s PTX-35 Co-stimulatory Antibody
  • Product Pipeline
    • Overview
    • HS-110
    • HS-130
    • COVID-19 Vaccine
    • PTX-35
    • Expanded Access
    • Scientific Publications
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • Corporate Presentation
  • News & Media
    • News Releases
    • Events
  • Careers
  • Contact

News Releases

News & Media

News & Media

  • News Releases
  • Events

Heat Biologics Appoints Louis C. Bock to Board of Directors

Sep 25, 2013

Heat Biologics, Inc. to Present at Aegis Capital Corp. 2013 Healthcare Conference

Sep 19, 2013

Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option

Sep 4, 2013

Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option

Aug 13, 2013

Heat Biologics, Inc. Announces Closing of Initial Public Offering of 2,500,000 Shares of Common Stock

Jul 29, 2013
    • 1...
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    © 2021 Heat Biologics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap LinkedIn